Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, March 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 44 publications that cite this research output.

44

The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.

Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment

Article in Cellular and Molecular Neurobiology (May 2024)

Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents

Article in Journal of Drug Targeting (May 2024)

Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy

Article in Biomedicine & Pharmacotherapy (April 2024)